Related Experiment Video
Updated: Mar 25, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Appendiceal Goblet Cell Adenocarcinoma With Mismatch Repair Deficiency and Microsatellite Instability-High Status: A
Hirotsugu Hashimoto1,2, Hirotomo Koda2, Kentaro Nakajima3
1Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.
Abstract:
Appendiceal goblet cell adenocarcinoma (GCA) is a rare amphicrine neoplasm, which recent studies have characterized as mismatch repair proficient and microsatellite stable. A 49-year-old male presented to our hospital with a Borrmann type 3-like ileocecal tumor extending continuously from a markedly swollen appendix. The patient underwent ileocecal resection. Pathologically, the tumor was diagnosed as high-grade appendiceal GCA, accompanied by lymphocytic infiltration, staged as pStage IVB. Immunohistochemistry revealed loss of MSH2 and MSH6 expression, indicating mismatch repair deficiency (dMMR), and molecular analysis confirmed microsatellite instability (MSI)-high status. Postoperatively, the patient was treated with chemotherapy, including immune checkpoint inhibitors as second-line therapy, which provided temporary relief of duodenal stenosis caused by tumor metastasis. However, the patient died of disease progression 37 months after surgery. To our knowledge, this is the first report of appendiceal GCA with dMMR and MSI-high status. Our findings underscore the necessity of incorporating MMR/MSI testing into the diagnostic workup of rare tumors such as GCA, particularly in young patients or those with a family history suggestive of Lynch syndrome, to optimize personalized treatment strategies.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mismatch Repair
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells

